LOC647859 expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 9.710400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
3.831400E-01
Normal-vs-Stage2
8.423400E-01
Normal-vs-Stage3
9.695700E-02
Normal-vs-Stage4
2.642600E-01
Stage1-vs-Stage2
1.931430E-01
Stage1-vs-Stage3
1.199600E-01
Stage1-vs-Stage4
1.402430E-01
Stage2-vs-Stage3
5.295700E-02
Stage2-vs-Stage4
6.403800E-01
Stage3-vs-Stage4
7.397200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
9.762400E-01
Normal-vs-AfricanAmerican
2.471800E-01
Normal-vs-Asian
4.225400E-01
Caucasian-vs-AfricanAmerican
1.210040E-01
Caucasian-vs-Asian
1.803550E-01
AfricanAmerican-vs-Asian
9.554600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
8.733800E-01
Normal-vs-Female
9.170600E-01
Male-vs-Female
3.129600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
7.878600E-01
Normal-vs-Age(41-60Yrs)
9.123600E-01
Normal-vs-Age(61-80Yrs)
9.307000E-01
Normal-vs-Age(81-100Yrs)
3.170800E-01
Age(21-40Yrs)-vs-Age(41-60Yrs)
8.262800E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
9.586200E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
5.179200E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
4.994800E-01
Age(41-60Yrs)-vs-Age(81-100Yrs)
1.156230E-01
Age(61-80Yrs)-vs-Age(81-100Yrs)
2.030000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
9.390000E-01
Normal-vs-Daily Drinker
9.187800E-01
Normal-vs-Weekly Drinker
2.501400E-01
Normal-vs-Occasional Drinker
8.017400E-01
Normal-vs-Social Drinker
4.796400E-01
Non Drinker-vs-Daily Drinker
9.539400E-01
Non Drinker-vs-Weekly Drinker
1.958390E-01
Non Drinker-vs-Occasional Drinker
6.987800E-01
Non Drinker-vs-Social Drinker
2.436200E-01
Daily Drinker-vs-Weekly Drinker
2.319600E-01
Daily Drinker-vs-Occasional Drinker
7.561800E-01
Daily Drinker-vs-Social Drinker
2.679800E-01
Weekly Drinker-vs-Occasional Drinker
1.711370E-01
Weekly Drinker-vs-Social Drinker
9.764400E-01
Occasional Drinker-vs-Social Drinker
1.939370E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
N/A
Normal-vs-Grade 2
N/A
Normal-vs-Grade 3
N/A
Normal-vs-Grade 4
N/A
Grade 1-vs-Grade 2
4.955600E-01
Grade 1-vs-Grade 3
8.097400E-01
Grade 1-vs-Grade 4
N/A
Grade 2-vs-Grade 3
2.325000E-01
Grade 2-vs-Grade 4
N/A
Grade 3-vs-Grade 4
N/A
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
2.171200E-01
Normal-vs-NonDiabetic
9.146800E-01
Diabetic-vs-NonDiabetic
7.039600E-03
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
9.341200E-01
Normal-vs-NoPancreatitis
9.624200E-01
Pancreatitis-vs-NoPancreatitis
9.452600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
8.789000E-01
Normal-vs-N1
8.878600E-01
N0-vs-N1
3.529400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
8.667200E-01
Normal-vs-TP53-NonMutant
7.793000E-01
TP53-Mutant-vs-TP53-NonMutant
6.738800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
